BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 781404)

  • 1. Cell-mediated immune response in head and neck cancer patients.
    Olivari A; Pradier R; Feierstein J; Guardo A; Glait H; Rojas A
    J Surg Oncol; 1976; 8(4):287-94. PubMed ID: 781404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP; Chretien PB
    Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
    [No Abstract]   [Full Text] [Related]  

  • 4. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
    Maisel RH; Ogura JH
    Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic evaluation and prognosis in patients with head and neck cancer.
    Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
    Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract.
    Gilbert HA; Kagan AR; Miles J; Flores L; Nussbaum H; Rao AR; Chan P
    J Surg Oncol; 1978; 10(1):73-7. PubMed ID: 628221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of cellular immunity in patients with malignant tumors].
    Niksic M; Balogh M; Jurin M
    Rev Laryngol Otol Rhinol (Bord); 1976; 97(9-10):387-96. PubMed ID: 794967
    [No Abstract]   [Full Text] [Related]  

  • 8. [Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)].
    Bier J; Nicklisch U
    Arch Otorhinolaryngol; 1981; 232(2):145-63. PubMed ID: 6973965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunity in patients with epidermoid cancer of the head and neck.
    Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
    Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy.
    Zighelboim J; Dorey F; Parker NH; Calcaterra T; Ward P; Fahey JL
    Cancer; 1979 Jul; 44(1):117-23. PubMed ID: 313240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the immunology of head and neck cancer--a prognostic index. Preliminary communication.
    Parker R; Alexander S; Shaheen OH; Parkes P
    J Laryngol Otol; 1975 Jul; 89(7):687-95. PubMed ID: 1185059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell deficiency in patients with squamous cell cancer of the head and neck.
    Wanebo HJ; Jun MY; Strong EW; Oettgen H
    Am J Surg; 1975 Oct; 130(4):445-51. PubMed ID: 1101724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological status of patients in carcinoma head and neck.
    Vasenwala SM; Aziz M; Rattan A; Ahmad KN
    Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological significance of lymphoreticular infiltration in gastrointestinal cancer.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    J Surg Oncol; 1981; 16(3):205-13. PubMed ID: 7218803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed hypersensitivity in patients treated by curative radiotherapy. Its relation to tumor response and short-term survival.
    Bosworth JL; Ghossein NA; Brooks TL
    Cancer; 1975 Aug; 36(2):353-8. PubMed ID: 1157006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy.
    Stefano S; Kerman R; Abbate J
    AJR Am J Roentgenol; 1976 Apr; 126(4):880-6. PubMed ID: 179361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immune profile and T-lymphocyte blocking factors in cancer of the head and neck and their prognostic significance.
    Sinha R; Gupta SC; Naithani YP
    Indian J Cancer; 1985 Mar; 22(1):8-16. PubMed ID: 3879757
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.
    Nemoto T; Han T; Minowada J; Angkur V; Chamberlain A; Dao L
    J Natl Cancer Inst; 1974 Sep; 53(3):641-5. PubMed ID: 4606319
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of radial radiotherapy on delayed hypersensitivity and the inflammatory response.
    Ghossein NA; Bosworth JL; Bases RE
    Cancer; 1975 Jun; 35(6):1616-20. PubMed ID: 1148994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.